Unichem Laboratories Ltd (UNICHEMLAB) is currently trading at 504.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients and operates through four divisions. It has five manufacturing facilities across India, enjoying numerous global certifications. The company has a rich history of collaborations and initiatives, having set up various R&D centers and strategic plants since its inception in 1962, illustrating its commitment to growth and innovation. Recent strategic moves include a significant acquisition by Ipca Laboratories Limited, which now holds majority control over Unichem, influencing its future trajectory and operational strategies. Despite divesting some business components in the past, Unichem continues to expand its international presence, notably with a wholly owned subsidiary in China, reflecting its global ambitions.

Over the past 52 weeks, Unichem Laboratories Ltd has traded between a low of ₹280.00 and a high of ₹685.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Unichem Laboratories Ltd has a market capitalization of approximately 3,549.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Unichem Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.65 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 3,549.51 Cr, Unichem Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Unichem Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Unichem Laboratories Ltd is 11.65. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The reported CGST penalty amount is ₹87.07 crore in the Order-in-Appeal from the Commissioner (Appeals), Thane dated September 18, 2026.

Unichem Laboratories reported a net profit of ₹41.47 crore for the quarter, compared with a net loss of ₹10.47 crore in the year-ago quarter.

Unichem’s consolidated Q4 net profit was ₹11 crore, down from ₹53 crore in the same quarter last year, a 79.2% year-on-year decline.